medically.roche.com

Backlink analytics and domain authority

Backlinks
All Dofollow Nofollow UGC DR ▾ Ref. domains ▾
+ Add filter
50 backlinks All New Lost
Referring page DR Ref. domains Linked domains Anchor and target URL
Foundation Medicine
https://medically.gene.com/global/en/oncology/diseases/foundation-medicine.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Omalizumab Treatment of Chronic Spontaneous Urticaria: Effectiveness and Sati...
https://medically.gene.com/global/en/unrestricted/respiratory/ACAAI-2022/acaai-2022-poster-seetasith-omalizumab-treatment-of-chr.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Impact of the Optimization of Surgical Procedure on the Incidence of Endophth...
https://medically.gene.com/global/en/unrestricted/ophthalmology/ASRS-2025/asrs-2025-presentation-chang-impact-of-the-optimization.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Marketing in a Digital Age and Corporate Social Responsibility | Ivory Research
https://www.ivoryresearch.com/samples/marketing-in-a-digital-age-and-corporate-social-responsibility
ivoryresearch.com
17 28 209
https://medically.roche.com/content/dam/pdmahub/non-restricted/oncology/esmo-asia-2019/ESMO-Asia-2019-presentation-cheng-IMbrave150-efficacy-and-safety-results-from-a-ph-3-study-evaluating-Atezolizumab-plus-Bevacizumab.pdf
https://medically.roche.com/content/dam/pdmahub/non-restricted/oncology/esmo-asia-2019/ESMO-Asia-2019-presentation-cheng-IMbrave150-efficacy-and-safety-results-from-a-ph-3-study-evaluating-Atezolizumab-plus-Bevacizumab.pdf
DOFOLLOW
JOS 2025
https://medically.gene.com/global/en/ophthalmology/congresses/jos-2025.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Pharmacokinetics and Coagulation Biomarkers in Persons with Hemophilia A (PwH...
https://medically.gene.com/global/en/unrestricted/haematology/diseases/materials/pharmacokinetics-and-coagulation-biomarkers-in-persons-.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
emicizumab_-pediatric-experience-in-clinical-studies-an.html
https://medically.gene.com/global/en/unrestricted/haematology/diseases/hemophilia/materials/emicizumab_-pediatric-experience-in-clinical-studies-an.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Novel Approaches to Amyloid: Trontinemab and Beyond
https://medically.gene.com/global/en/unrestricted/neuroscience/AAIC-2024/aaic-2024-presentation-kerchner-novel-approaches-to-amy.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
ASH 2023
https://medically.gene.com/global/en/Haematology/Congresses/ash-2023.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Real-World Treatment Patterns for Chronic Spontaneous Urticaria: Is Omalizuma...
https://medically.gene.com/global/en/unrestricted/neuroscience/AMCP-NEXUS-2022/amcp-nexus-2022-poster-seetasith-real-world-treatment-p.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
EURETINA 2025
https://medically.gene.com/global/en/ophthalmology/congresses/euretina-2025.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
ASH 2023 Trials in progress: The randomized, double-blind, placebo-controlled...
https://medically.gene.com/global/en/unrestricted/haematology/ASH-2023/ash-2023-poster-araujo-ash-2023-trials-in-progress.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Baloxavir marboxil▼ single-dose treatment in otherwise-healthy children aged ...
https://medically.gene.com/global/en/unrestricted/infectious-disease/ESPID-2024/espid-2024-presentation-palmu-baloxavir-marboxil-single.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Greater Baseline Disease Burden and Risk for Disability Progression in Self-R...
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
SUO 2024
https://medically.gene.com/global/en/oncology/congresses/suo-2024.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Hospitalizations and Emergency Department Visits Before and After Omalizumab ...
https://medically.gene.com/global/en/unrestricted/immunology/AAAAI-2024/aaaai-2024-presentation-bird-d-hospitalizations-and-eme.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
ESH-CART 2025
https://medically.gene.com/global/en/Haematology/Congresses/esh-cart-2025.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
EULAR 2024
https://medically.gene.com/global/en/nephrology/congresses/eular-2024.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Clinical Benefits of Continuous Delivery of Anti-VEGF Ranibizumab with the Po...
https://medically.gene.com/global/en/unrestricted/ophthalmology/EURETINA-2024/euretina-2024-presentation-zinkernagel-clinical-benefit.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
AMCP-Nexus-2024-poster-lin-real-world-treatment-patterns.html
https://medically.gene.com/global/en/unrestricted/oncology/AMCP-NEXUS-2024/AMCP-Nexus-2024-poster-lin-real-world-treatment-patterns.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Home
https://floretina.com/
floretina.com
14 10 22
Floretina Banner
https://medically.roche.com/global/en/ophthalmology/floretina-2025.html
DOFOLLOW
TIGIT and PD-L1 co-blockade promotes functional differentiation and clonal ex...
https://medically.gene.com/global/en/unrestricted/oncology/SITC-2023/sitc-2023-poster-nutsch-tigit-and-pd-l1-co-blockade.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
The Impact of Continuous Delivery of Ranibizumab in Patients With Neovascular...
https://medically.gene.com/global/en/unrestricted/ophthalmology/EURETINA-2024/euretina-2024-presentation-chakravarthy-the-impact-of-c.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
One-Year Analysis of Efficacy and Safety Data From Black/African American and...
https://medically.gene.com/global/en/unrestricted/neuroscience/AAN-2024/aan-2024-presentation-amezcua-one-year-analysis-of-effi.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Pooled analyses of immune-related adverse events (irAEs) and efficacy from th...
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
EHDN 2024
https://medically.gene.com/global/en/neuroscience/Congresses/ehdn-2024.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
ERS 2025
https://medically.gene.com/global/en/respiratory/congresses/ers-2025.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Patient Preference for the Port Delivery System With Ranibizumab (PDS) vs Int...
https://medically.gene.com/global/en/unrestricted/ophthalmology/EURETINA-2024/euretina-2024-presentation-chang-patient-preference-for.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Placebo response in HD: Comparing placebo arm in GENERATION HD1 vs Enroll-HD ...
https://medically.gene.com/global/en/unrestricted/neuroscience/EHDN-2024/ehdn-2024-presentation-boareto-placebo-response-in-hd-c.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
T-cell response to micro-dystrophin in a patient treated with delandistrogene...
https://medically.gene.com/global/en/unrestricted/neuroscience/WMS-2023/wms-2023-poster-potter-t-cell-response-to-srp-9001-dyst.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Subcutaneous Ocrelizumab in Patients with Multiple Sclerosis: Results of the ...
https://medically.gene.com/global/en/unrestricted/neuroscience/ECTRIMS-2023/ectrims-2023-poster-newsome-sd-subcutaneous-ocrelizumab.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Real-World Treatment Patterns and Visual Outcomes of Faricimab▼ Use Among Eye...
https://medically.gene.com/global/en/unrestricted/ophthalmology/EURETINA-2024/euretina-2024-presentation-mckibbin-real-world-treatmen.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
ESMO Asia 2023
https://medically.gene.com/global/en/oncology/congresses/esmo-asia-2023.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Placental and Breastmilk Transfer of Ocrelizumab From Women With Multiple Scl...
https://medically.gene.com/global/en/unrestricted/neuroscience/CMSC-2025/cmsc-2025-presentation-bove-placental-and-breastmilk-tr.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Morph-interpolation visualizations of the effect of monthly intravitreal inje...
https://medically.gene.com/global/en/unrestricted/ophthalmology/ASRS-2023/asrs-2023-presentation-yonekawa-morph-interpolation-vis.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Rheumatology
https://medically.gene.com/global/en/rheumatology.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
NBDF 2024
https://medically.gene.com/global/en/Haematology/Congresses/nbdf-2024.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
IMpower010: Digital pathology (DP) vs manual SP263 PD-L1 tumour cell (TC) sco...
https://medically.gene.com/global/en/unrestricted/oncology/ELCC-2025/elcc-2025-poster-reck-impower010-digital-pathology-dp-v.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
EHA 2025
https://medically.gene.com/global/en/Haematology/Congresses/eha-2025.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Phase I study of divarasib (GDC-6036) in Japanese patients with locally advan...
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Health-related quality of life (HRQoL) results for adjuvant alectinib vs chem...
https://medically.gene.com/global/en/unrestricted/oncology/annual-meeting-2024/oncology-annual-meeting-2024-presentation-nishio-health.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Glofitamab▼ plus gemcitabine and oxaliplatin (GLOFIT-GEMOX) for relapsed/refr...
https://medically.gene.com/global/en/unrestricted/haematology/EHA-2024/eha-2024-presentation-abramson-glofitamab-plus-gemcitab.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
AAMDSIF 2023
https://medically.gene.com/global/en/Haematology/Congresses/aamdsif-2023.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Exploration of the use of risdiplam▼ administration in patients with SMA who ...
https://medically.gene.com/global/en/unrestricted/neuroscience/SMA-EUROPE-2024/sma-eu-2024-poster-guittari-exploration-of-the-use-of-r.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
ESCMID 2025
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Individualized Faricimab▼ Dosing up to Every 16 weeks Maintains Robust Anatom...
https://medically.gene.com/global/en/unrestricted/ophthalmology/ASRS-2023/asrs-2023-presentation-chaudhary-individualized-faricim.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Infection in NMOSD: An analysis of the patterns of infections in SAkuraMoon (...
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Pharmacokinetic Profile of the Port Delivery System With Ranibizumab in the P...
https://medically.gene.com/global/en/unrestricted/ophthalmology/EURETINA-2023/euretina-2023-presentation-dhoot-pharmacokinetic-profil.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
National and State Population-Level Estimated Economic Impact of Ocrelizumab ...
https://medically.gene.com/global/en/unrestricted/oncology/ISPOR-2025/ispor-2025-poster-pineda-national-and-state-population-.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Two-year Results of Patient-Reported Outcomes in Patients with Multiple Scler...
https://medically.gene.com/global/en/unrestricted/neuroscience/ECTRIMS-2024/ectrims-2024-poster-trojano-two-year-results-of-patient.html
medically.gene.com
18 2 49
medically.roche.com
https://medically.roche.com/global/en.html
DOFOLLOW
Next page →
Frequently Asked Questions
How many backlinks does medically.roche.com have?
The backlinks page for medically.roche.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on medically.roche.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to medically.roche.com dofollow or nofollow?
Backlinks to medically.roche.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.